Drug Trial Radar · NCT04895696
A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
Last checked: Nov 19, 2026Latest source record: Aug 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
248
Actual
Start
Oct 11, 2021
Primary completion
Jun 12, 2026
Study completion Apr 22, 2029
Sponsor
- Lead sponsor
- Beeline Medicines CorporationIndustry
- Sponsor type
- Industry
- First posted
- May 20, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the effectiveness, safety and tolerability of Afimetoran in participants with active Systemic Lupus Erythematosus (SLE). The extension period will provide additional long-term safety and efficacy data and enable those participants initially randomized to placebo to receive treatment with Afimetoran.
Conditions
- Systemic Lupus Erythematosus
Interventions
AfimetoranDrug
Specified dose on specified days
PlaceboOther
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants that achieve an SLE (Systemic Lupus Erythematosus) Responder Index (4) (SRI(4)) response at Week 48Time frame: Up to 48 Weeks
Locations
147 sites in 19 countries. Site status is shown where the registry gives one.
Local Institution - 0100
Birmingham, Alabama
Local Institution - 0123
Huntington Beach, California
Local Institution - 0170
La Jolla, California
Local Institution - 0159
La Palma, California
Local Institution - 0172
San Diego, California
Local Institution - 0164
Woodland Hills, California
Local Institution - 0121
Clearwater, Florida
Local Institution - 0167
Kissimmee, Florida
Local Institution - 0122
Orlando, Florida
Local Institution - 0173
Ormond Beach, Florida
Local Institution - 0154
Plantation, Florida
Local Institution - 0137
South Miami, Florida
Local Institution - 0155
Tamarac, Florida
Local Institution - 0160
Atlanta, Georgia
Local Institution - 0205
Suwanee, Georgia
Local Institution - 0146
Orland Park, Illinois
Local Institution - 0187
Hopkinsville, Kentucky
Local Institution - 0171
Baton Rouge, Louisiana
Local Institution - 0134
Wheaton, Maryland
Local Institution - 0070
Eagan, Minnesota
Local Institution - 0124
St Louis, Missouri
Local Institution - 0165
St Louis, Missouri
Local Institution - 0091
Las Vegas, Nevada
Local Institution - 0219
West Long Branch, New Jersey
Local Institution - 0140
Manhasset, New York
Local Institution - 0132
The Bronx, New York
Local Institution - 0203
Charlotte, North Carolina
Local Institution - 0103
Charlotte, North Carolina
Local Institution - 0151
Columbus, Ohio
Local Institution - 0042
Middleburg Heights, Ohio
Local Institution - 0152
Allen, Texas
Local Institution - 0197
Allen, Texas
Local Institution - 0136
Amarillo, Texas
Local Institution - 0029
Mesquite, Texas
Local Institution - 0163
San Antonio, Texas
Local Institution - 0223
Bellevue, Washington
Local Institution - 0207
Buenos Aires, Buenos Aires, Argentina
Local Institution - 0128
Buenos Aires, Buenos Aires, Argentina
Local Institution - 0130
Quilmes, Buenos Aires, Argentina
Local Institution - 0195
San Fernando, Buenos Aires, Argentina
Showing 40 of 147 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.